Publicação
How to raise capital for a MedTech company - a route to commercialization
| datacite.subject.fos | Ciências Sociais::Economia e Gestão | pt_PT |
| dc.contributor.advisor | Jacinto, Maria João | |
| dc.contributor.author | Riethmüller, Sophie | |
| dc.date.accessioned | 2025-08-08T13:30:55Z | |
| dc.date.embargo | 2027-12-17 | |
| dc.date.issued | 2025-01-14 | |
| dc.date.submitted | 2024-12-17 | |
| dc.description.abstract | This work project explores strategic steps for CancerCo, a MedTech start-up, to commercialize its metastasis-targeting technologies. It analyzes CancerCo’s position within regulatory frameworks, the competitive landscape, and funding ecosystems, focusing on challenges and strategies for market entry. By comparing regulatory pathways in the US and EU, assessing funding strategies, and analyzing competitors, the research proposes an actionable go-to-market strategy. It concludes with a roadmap for CancerCo’s long-term growth, emphasizing regulatory navigation, collaborations, and US market positioning. These recommendations aim to strengthen CancerCo’s market presence and go-to-market strategy toward commercialization. | pt_PT |
| dc.identifier.tid | 203962214 | pt_PT |
| dc.identifier.uri | http://hdl.handle.net/10362/186206 | |
| dc.language.iso | eng | pt_PT |
| dc.subject | MedTech | pt_PT |
| dc.subject | Oncology | pt_PT |
| dc.subject | Personalized Medicine | pt_PT |
| dc.subject | AI Technology | pt_PT |
| dc.subject | Cancer drug discovery | pt_PT |
| dc.title | How to raise capital for a MedTech company - a route to commercialization | pt_PT |
| dc.type | master thesis | |
| dspace.entity.type | Publication | |
| rcaap.rights | embargoedAccess | pt_PT |
| rcaap.type | masterThesis | pt_PT |
| thesis.degree.name | A Work Project, presented as part of the requirements for the Award of a Master’s degree in Impact Entrepreneurship and Innovation from the Nova School of Business and Economics | pt_PT |